IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.
Cochaud S, Giustiniani J, Thomas C, Laprevotte E, Garbar C, Savoye AM, Curé H, Mascaux C, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A, Bastid J.
Cochaud S, et al. Among authors: garbar c.
Sci Rep. 2013 Dec 9;3:3456. doi: 10.1038/srep03456.
Sci Rep. 2013.
PMID: 24316750
Free PMC article.